Real-time enrollment status for this transthyretin amyloid cardiomyopathy clinical trial
Current Status
Recruiting
Checked: October 10, 2026 at 9:46 PM UTC
| NCT Number | NCT07690436 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloid Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 6 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 10, 2026: Clinical trial NCT07690436 is currently recruiting participants. This clinical trial study for transthyretin amyloid cardiomyopathy is actively seeking new participants at 6 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07690436 is actively recruiting participants as of October 10, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07690436 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.